Hind Anan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hind Anan has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Elizabeth Andraska
Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA
2 shared publications- Fanny Alie-Cusson
Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA; Sanger Heart and Vascular Institute, Atrium Health, Charlotte, NC
2 shared publications - Marissa C. Jarosinski
Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA
2 shared publications - Natalie D. Sridharan
Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA
2 shared publications Rabih Chaer
Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA; Division of Vascular and Endovascular Surgery, Department of Surgery, Stony Brook University Hospital, Stony Brook, NY
2 shared publicationsYashashwini Sudina
2 shared publications
Latest Publications
- 10 October 2026
- Published by Elsevier in Journal of Vascular Surgery
Multicenter Outcomes of Peripheral Vascular Interventions in Patients with Active Cancer
- 10 October 2026
- Published by Elsevier in Journal of Vascular Surgery
Multicenter Outcomes of Peripheral Vascular Interventions in Patients with Active Cancer
- Open Access
- 5 May 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (8) , 1807-1814
Contemporary Comparison between the Hemodialysis Reliable Outflow Device and Femoral Arteriovenous Graft
Key Points: Previously, femoral arteriovenous grafts were the standard approach for patients with upper extremity central venous occlusion. In our study, hemodialysis reliable outflow offered a higher likelihood of obtaining functional patency and fewer complications compared with femoral arteriovenous graft. These findings highlight that hemodialysis reliable outflow graft is a viable option for patients who have exhausted upper extremity arteriovenous access. Background: Hemodialysis reliable outflow (HeRO) graft and femoral arteriovenous graft (fAVG) are alternative options for patients who have exhausted upper extremity arteriovenous access because of central venous occlusion. This study aims to provide a contemporary comparison between HeRO and fAVG. Methods: Retrospective chart review of consecutive fAVG and HeRO placed between 2016 and 2023 at a multihospital health care system was conducted. Patients were identified using the local Vascular Quality Initiative database and supplemented by charts review. Baseline characteristics, operative details, and follow-up data were obtained. Data were analyzed using standard statistical tests, Kaplan–Meier survival analysis, and multivariate Cox proportional hazards. Results: Data for 114 access were collected (68 HeRO, 46 fAVG) from 105 unique patients. Patients receiving HeRO graftswere older (66.1 versus 57.7 years), had higher body mass index (31.8 versus 27.9 kg/m 2 ), and were more likely to have a history of atrial fibrillation (56% versus 20%) and fewer previous arteriovenous accesses (mean 1.4 versus 2.4). The ability to use the graft for hemodialysis was higher in the HeRO group (94% versus 83%; P = 0.049). At 36 months, the primary patency rate was 5% for the HeRO graft and 17% for the fAVG ( P = 0.45), while the secondary patency rates were 30% and 54% ( P = 0.25), respectively. Thrombosis was the predominant cause of HeRO graft abandonment (78%), whereas infection was most common for fAVGs (44%). On Kaplan‑Meier analysis, mortality was similar for HeRO graft and fAVG ( P = 0.22). Six (9%) patients from the HeRO group and ten (22%) from the fAVG group underwent graft removal because of infection ( P = 0.05). The rate of steal did not differ between both groups (HeRO 6% versus fAVG 11%; P = 0.33); however, among patients receiving fAVG, two required access ligation and two underwent limb amputation (HeRO, 0% versus fAVG, 9%; P = 0.01). Conclusions: HeRO graft is a reasonable alternative for patients who have exhausted upper extremity arteriovenous access, offering a higher likelihood of obtaining functional patency and fewer complications compared with fAVG.
- 5 May 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (8) , 1807-1814
Open AccessContemporary Comparison between the Hemodialysis Reliable Outflow Device and Femoral Arteriovenous Graft
Key Points: Previously, femoral arteriovenous grafts were the standard approach for patients with upper extremity central venous occlusion. In our study, hemodialysis reliable outflow offered a higher likelihood of obtaining functional patency and fewer complications compared with femoral arteriovenous graft. These findings highlight that hemodialysis reliable outflow graft is a viable option for patients who have exhausted upper extremity arteriovenous access. Background: Hemodialysis reliable outflow (HeRO) graft and femoral arteriovenous graft (fAVG) are alternative options for patients who have exhausted upper extremity arteriovenous access because of central venous occlusion. This study aims to provide a contemporary comparison between HeRO and fAVG. Methods: Retrospective chart review of consecutive fAVG and HeRO placed between 2016 and 2023 at a multihospital health care system was conducted. Patients were identified using the local Vascular Quality Initiative database and supplemented by charts review. Baseline characteristics, operative details, and follow-up data were obtained. Data were analyzed using standard statistical tests, Kaplan–Meier survival analysis, and multivariate Cox proportional hazards. Results: Data for 114 access were collected (68 HeRO, 46 fAVG) from 105 unique patients. Patients receiving HeRO graftswere older (66.1 versus 57.7 years), had higher body mass index (31.8 versus 27.9 kg/m 2 ), and were more likely to have a history of atrial fibrillation (56% versus 20%) and fewer previous arteriovenous accesses (mean 1.4 versus 2.4). The ability to use the graft for hemodialysis was higher in the HeRO group (94% versus 83%; P = 0.049). At 36 months, the primary patency rate was 5% for the HeRO graft and 17% for the fAVG ( P = 0.45), while the secondary patency rates were 30% and 54% ( P = 0.25), respectively. Thrombosis was the predominant cause of HeRO graft abandonment (78%), whereas infection was most common for fAVGs (44%). On Kaplan‑Meier analysis, mortality was similar for HeRO graft and fAVG ( P = 0.22). Six (9%) patients from the HeRO group and ten (22%) from the fAVG group underwent graft removal because of infection ( P = 0.05). The rate of steal did not differ between both groups (HeRO 6% versus fAVG 11%; P = 0.33); however, among patients receiving fAVG, two required access ligation and two underwent limb amputation (HeRO, 0% versus fAVG, 9%; P = 0.01). Conclusions: HeRO graft is a reasonable alternative for patients who have exhausted upper extremity arteriovenous access, offering a higher likelihood of obtaining functional patency and fewer complications compared with fAVG.
- Open Access
- 2 March 2026
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 14 (4) , 102469
Stenting for symptomatic left renal vein compression in patients with complex pelvic venous disease is safe on long-term follow-up
- 2 March 2026
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 14 (4) , 102469
Open AccessStenting for symptomatic left renal vein compression in patients with complex pelvic venous disease is safe on long-term follow-up
- Open Access
- 16 December 2025
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 14 (2) , 102379
Catheter-directed interventions versus surgical embolectomy in massive pulmonary embolism
- 16 December 2025
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 14 (2) , 102379
Open AccessCatheter-directed interventions versus surgical embolectomy in massive pulmonary embolism
- 19 June 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 82 (4) , 1485-1494
Comparative effectiveness of suction thrombectomy versus catheter-directed thrombolysis in intermediate-risk pulmonary embolism
- 19 June 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 82 (4) , 1485-1494
Comparative effectiveness of suction thrombectomy versus catheter-directed thrombolysis in intermediate-risk pulmonary embolism